Regulatory mechanisms of erythropoietin levels in dialysis patients

  • TAGAWA HITOSHI
    Department of Internal Medicine, Mitsui Memorial Hospital
  • UMEZU MICHIO
    Department of Internal Medicine, Mitsui Memorial Hospital
  • SAITO TSUNEHIRO
    Department of Internal Medicine, Mitsui Memorial Hospital
  • YAMAKADO MINORU
    Department of Internal Medicine, Mitsui Memorial Hospital
  • NAGANO MASASHI
    Department of Internal Medicine, Mitsui Memorial Hospital
  • URABE AKIO
    The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo
  • TAKAKU FUMIMARO
    The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo

抄録

We described a radioimmunoassay system for measuring blood erythropoietin (Epo) levels using recombinant human Epo and evaluated the regulatory mechanisms of Epo in dialysis patients. A satisfactory dose-response relationship for Epo levels was observed within the wide range of 3-250 mU/ml with a sensitivity of approximately 5mU/ml. The Epo levels were found to be 16.1 ± 8.6 mU/ml (m ± SD) in 422 uremic patients on maintenance dialysis and 17.1 ±7.2 mU/ml in 86 normal subjects. The Epo levels were not statistically different between the two groups, although the hematocrit was significantly lower in the dialysis patients. No correlation was observed between the Epo levels and hematocrit in the dialysis patients. Patients with polycystic kidneys had higher hematocrits and Epo levels than patients with chronic nephritis. No changes in Epo levels were observed with age and with the period of dialysis. Diurnal variations in the Epo levels revealed a significant increase after hemodialysis, and an acute reduction in hematocrit following massive hemorrhage raised the Epo levels up to 3, 180 mU/ml. These findings indicate that the Epo levels in dialysis patients are inappropriately low for the severity of anemia and suggest that a negative feedback mechanism of the hematocrit on the Epo secretion may exist in uremic patients as well as in normal subjects and that the threshold for Epo secretion might be 'reset' at a low hematocrit level.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390001204860757632
  • NII論文ID
    130004169687
  • DOI
    10.14842/jpnjnephrol1959.32.297
  • ISSN
    18840728
    03852385
  • PubMed
    2355666
  • 本文言語コード
    en
  • データソース種別
    • JaLC
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ